Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Share this content:
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Sponsors and Collaborators
Abramson Cancer Center of the University of Pennsylvania

Principal Investigator
Stephen Keefe, Abramson Cancer Center of the University of Pennsylvania

ClinicalTrials.gov Identifier
NCT01026337

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters